Pablo Ortiz
Overview
Explore the profile of Pablo Ortiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narawane A, Ortiz P, Draelos M, McNabb R, Kuo A, Izatt J
Opt Lett
. 2025 Mar;
50(6):1969-1972.
PMID: 40085605
Optical coherence tomography (OCT) systems utilize 2D scanning methods to acquire reflectance-based volumetric images of samples, such as the human retina, with micrometer-scale depth resolution. A common method for performing...
2.
Martinez A, Navajas-Guerrero A, Bediaga-Baneres H, Sanchez-Bodon J, Ortiz P, Vilas-Vilela J, et al.
Polymers (Basel)
. 2024 Oct;
16(20).
PMID: 39458764
Recent advancements in materials science have garnered significant attention within the research community. Over the past decade, substantial efforts have been directed towards the exploration of innovative methodologies for developing...
3.
Noureddin M, Truong E, Mayo R, Martinez-Arranz I, Minchole I, Banales J, et al.
Hepatology
. 2024 Sep;
81(1):E12-E16.
PMID: 39325967
No abstract available.
4.
Draelos M, Ortiz P, Narawane A, McNabb R, Kuo A, Izatt J
Int Symp Med Robot
. 2024 Aug;
2023.
PMID: 39092148
Ophthalmic optical coherence tomography (OCT) has achieved remarkable clinical success but remains sequestered in ophthalmology specialty offices. Recently introduced robotic OCT systems seek to expand patient access but fall short...
5.
Lin K, Amigo N, Ortiz P, Alonso C, Smolensky A, Parmar D, et al.
Clin Investig Arterioscler
. 2024 Jun;
37(1):100723.
PMID: 38945785
Background And Aims: Comprehensive assessment of pharmacotherapy effects on atherogenic parameters (AP) that influence the risk of cardiovascular disease (CVD) is challenging due to interactions among a large number of...
6.
Mitsunaga K, Bagot M, Ram-Wolff C, Guenova E, von Gugelberg C, Hodak E, et al.
Br J Dermatol
. 2024 Apr;
191(3):419-427.
PMID: 38596857
Background: Mycosis fungoides (MF) and Sézary syndrome (SS) are chronic malignant diseases that typically necessitate diverse strategies to achieve remission. Systemic interferon (IFN)-α (subtypes 2a and 2b) has been used...
7.
Fernandez-Guarino M, Ortiz P, Gallardo F, Llamas-Velasco M
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396877
Mogamulizumab (MOG) is an antibody targeting the CCR4 receptor, authorized for relapsed or refractory peripheral T-cell (PTCL) and cutaneous T-cell lymphomas (CTCL). Its adoption in guidelines and endorsement by FDA...
8.
Noureddin M, Truong E, Mayo R, Martinez-Arranz I, Minchole I, Banales J, et al.
Hepatology
. 2023 Jul;
79(1):135-148.
PMID: 37505221
Background: Early identification of those with NAFLD activity score ≥ 4 and significant fibrosis (≥F2) or at-risk metabolic dysfunction-associated steatohepatitis (MASH) is a priority as these patients are at increased...
9.
Gomez-Olivas J, Campos-Rodriguez F, Nagore E, Martorell A, Garcia-Rio F, Cubillos C, et al.
Chest
. 2023 Jun;
164(6):1551-1559.
PMID: 37348828
Background: OSA has been associated with increased incidence and aggressiveness of melanoma. However, the long-term impact of OSA and CPAP treatment on the prognosis of melanoma remains unexplored. Research Question:...
10.
Umanath K, She R, Hassett C, Adrianto I, Levin A, Savickas G, et al.
J Am Heart Assoc
. 2023 Mar;
12(6):e026242.
PMID: 36892045
Background The renal mechanisms involved in the maintenance of human hypertension and resistance to treatment are not well understood. Animal studies suggest that chronic renal inflammation contributes to hypertension. We...